Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 8(1): 10550, 2018 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-30002429

RESUMEN

In Escherichia coli, an increase in the frequency of chromosome replication is lethal. In order to identify compounds that affect chromosome replication, we screened for molecules capable of restoring the viability of hyper-replicating cells. We made use of two E. coli strains that over-initiate DNA replication by keeping the DnaA initiator protein in its active ATP bound state. While viable under anaerobic growth or when grown on poor media, these strains become inviable when grown in rich media. Extracts from actinomycetes strains were screened, leading to the identification of deferoxamine (DFO) as the active compound in one of them. We show that DFO does not affect chromosomal replication initiation and suggest that it was identified due to its ability to chelate cellular iron. This limits the formation of reactive oxygen species, reduce oxidative DNA damage and promote processivity of DNA replication. We argue that the benzazepine derivate (±)-6-Chloro-PB hydrobromide acts in a similar manner.


Asunto(s)
Replicación del ADN/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Quelantes del Hierro/farmacología , Proteínas Bacterianas/metabolismo , Cromosomas Bacterianos/efectos de los fármacos , Cromosomas Bacterianos/genética , Replicación del ADN/genética , ADN Bacteriano/genética , ADN Bacteriano/metabolismo , Proteínas de Unión al ADN/metabolismo , Deferoxamina/farmacología , Escherichia coli/genética , Escherichia coli/metabolismo , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Inhibidores de Topoisomerasa II/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA